Cargando…

Therapy of addition for Alzheimer's Disease: combination with galantamine and memantine

Detalles Bibliográficos
Autores principales: Zarra, Julio, Schmidt, Luisa
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991801/
http://dx.doi.org/10.1186/1744-859X-9-S1-S118
_version_ 1782192639227985920
author Zarra, Julio
Schmidt, Luisa
author_facet Zarra, Julio
Schmidt, Luisa
author_sort Zarra, Julio
collection PubMed
description
format Text
id pubmed-2991801
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29918012010-11-26 Therapy of addition for Alzheimer's Disease: combination with galantamine and memantine Zarra, Julio Schmidt, Luisa Ann Gen Psychiatry Meeting Abstract BioMed Central 2010-04-22 /pmc/articles/PMC2991801/ http://dx.doi.org/10.1186/1744-859X-9-S1-S118 Text en Copyright ©2009 Zarra et al; licensee BioMed Central Ltd.
spellingShingle Meeting Abstract
Zarra, Julio
Schmidt, Luisa
Therapy of addition for Alzheimer's Disease: combination with galantamine and memantine
title Therapy of addition for Alzheimer's Disease: combination with galantamine and memantine
title_full Therapy of addition for Alzheimer's Disease: combination with galantamine and memantine
title_fullStr Therapy of addition for Alzheimer's Disease: combination with galantamine and memantine
title_full_unstemmed Therapy of addition for Alzheimer's Disease: combination with galantamine and memantine
title_short Therapy of addition for Alzheimer's Disease: combination with galantamine and memantine
title_sort therapy of addition for alzheimer's disease: combination with galantamine and memantine
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991801/
http://dx.doi.org/10.1186/1744-859X-9-S1-S118
work_keys_str_mv AT zarrajulio therapyofadditionforalzheimersdiseasecombinationwithgalantamineandmemantine
AT schmidtluisa therapyofadditionforalzheimersdiseasecombinationwithgalantamineandmemantine